Patent · US Active

Oral dosage form

US10966928B2 · kind B2 · utility

0Cited by

2References

16Claims

0Family size

Assignee

UNIVERSITEIT GENT · BE

Inventors

Chris Vervaet · Kachtem, BE
Jean Paul Remon · Melle, BE
Glenn Verstraete · Rollegem-Kapelle, BE

Key dates

Filing date	Mar 13, 2020
Grant date	Apr 6, 2021
Priority date	—
Expiry date	Mar 13, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/167
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention in general relates to a pharmaceutical dosage form comprising one or more granules, and a method for manufacturing thereof. The granules of the dosage form are prepared via the extrusion/spheronization technique using partially hydrolysed polyvinyl alcohol. These granules have the advantage that a high drug load can be contained therein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.